As of 2026-09-19, the Intrinsic Value of agilon health Inc (AGL) is 20.76 USD. This AGL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 89.16 USD, the upside of agilon health Inc is -76.70%.
The range of the Intrinsic Value is 8.83 - 49.51 USD
Based on its market price of 89.16 USD and our intrinsic valuation, agilon health Inc (AGL) is overvalued by 76.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 8.83 - 49.51 | 20.76 | -76.7% |
| DCF (Growth 10y) | 110.32 - 290.40 | 163.30 | 83.2% |
| DCF (EBITDA 5y) | 48.92 - 67.43 | 53.36 | -40.2% |
| DCF (EBITDA 10y) | 131.25 - 180.42 | 146.02 | 63.8% |
| Fair Value | -69.61 - -69.61 | -69.61 | -178.07% |
| P/E | (297.09) - (337.47) | (320.55) | -459.5% |
| EV/EBITDA | (137.90) - (127.30) | (125.93) | -241.2% |
| EPV | (225.03) - (295.84) | (260.43) | -392.1% |
| DDM - Stable | (154.98) - (477.58) | (316.28) | -454.7% |
| DDM - Multi | 50.23 - 120.87 | 71.07 | -20.3% |
| Market Cap (mil) | 1,487.19 |
| Beta | 6.54 |
| Outstanding shares (mil) | 16.68 |
| Enterprise Value (mil) | 1,410.30 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.46% |
| Cost of Debt | 9.63% |
| WACC | 6.53% |